Table of Contents

Orgovyx (relugolix) is the first oral hormone therapy approved in the US. Unlike injectable therapies, Orgovyx is taken orally once daily, which some patients prefer. The drug was approved in 2020 and has been touted for its convenience and comparable efficacy to long-standing options such as leuprolide.

However, it comes with a substantial price tag. Many pharmacies charge more than $2,300 for a 30-day supply, and some reports list prices closer to $2,787 per month. This article explains why Orgovyx is expensive and offers practical ways to reduce your out-of-pocket costs.

Key Takeaways

  • US retail prices for Orgovyx range from about $2,313 to $2,787 for 30 tablets. At Pharma Giant, a 30-day supply of 120 mg Orgovyx tablets costs $419.99, and a 10% discount could lower that to approximately $377.99.
  • Orgovyx is only available as a brand-name drug, and the lack of a generic keeps prices high.
  • Financial assistance is available. Manufacturer programs can lower co-pays to as little as $10 per month for eligible commercially insured patients.
  • Ordering a 90-day supply and using mail-order or specialty pharmacies can reduce the per-tablet cost. At Pharma Giant, a 90-day supply of 120 mg Orgovyx tablets costs $1,230.

Why are new cancer drugs expensive?

Cancer medicines are among the most costly therapies available today. A 2023 review in Nature Reviews Clinical Oncology noted that 95% of new anticancer therapies launched at more than $100,000 per year, and prices typically rise after launch. Manufacturers often set prices as high as the market will tolerate, particularly when there are few alternative treatments.

The high cost reflects:

    • Extensive research and clinical trials. Decades of laboratory work, animal studies, and multi-phase human trials can cost billions of dollars. Only a small fraction of drug candidates ever make it to market.
    • Patent protection and exclusivity. Brand-name drugs enjoy years of market exclusivity, which allows companies to recoup research costs before generics appear. Because Orgovyx has no generic yet, competition is limited.
    • Complex manufacturing. Producing biologically active molecules requires specialized equipment and stringent quality controls.
    • Market factors. The US allows drug companies to set prices without government negotiation, resulting in prices two to three times higher than in other high-income countries.

How much does Orgovyx cost?

A 2020 report from BioSpace estimated the retail cost at about $2,313 per bottle for a 30-day supply. Meanwhile, Drugs.com lists a slightly higher figure of approximately $2,787 for the same amount, which breaks down to roughly $92.90 per tablet.

These prices do not account for insurance coverage, copay assistance, or manufacturer savings programs, which can significantly lower your costs.

But retail prices for Orgovyx can vary widely depending on the pharmacy you use and where you live. Factors such as regional pricing agreements, pharmacy markups, and supply chain differences all influence what you pay out of pocket.

Orgovyx coupons and discounts

Starts from $419.99

Have a prescription?

Choose Pharma Giant for affordable medications and take control of your health with reliable, cost-effective options today!

SAVE 10% with coupon code:

Comparison with other therapies

The injectable therapy leuprolide (Lupron) and its generics cost around $8,687 per three-month dose, though generic versions are available at about $2,729.

Orgovyx’s monthly price is similar to a single generic injection, but it must be taken every day, so the prices can quickly add up. The convenience of a daily pill and quick reversal of hormonal suppression are often cited as advantages that justify its higher price tag.

Factors driving the high cost of Orgovyx

Several factors contribute to the high price of Orgovyx in the US, including:

1. Limited competition and patent exclusivity

Orgovyx is the first and only oral GnRH antagonist for prostate cancer, which gives its manufacturer pricing leverage. Because generic relugolix is not available, there is no competitive pressure to lower prices.

2. Research and development costs

Developing a new cancer therapy involves thousands of scientists, years of research, and numerous clinical trials. The cost of failures is built into the price of successful drugs. Although the exact R&D cost for Orgovyx is proprietary, the high launch price reflects the general pattern of cancer drug development.

3. Regulatory and manufacturing expenses

Producing an oral peptide-based hormone therapy requires strict manufacturing controls and continuous monitoring. Regulatory compliance with the FDA’s quality standards adds to the expense.

4. Value-based pricing

Orgovyx offers a convenient alternative to injections and may lower the risk of cardiovascular events compared with some injectable therapies.

In the pivotal clinical trial (the HERO study), approximately 97% of patients lowered their testosterone to castrate levels (< 50 ng/dL) by day 29 and maintained it through 48 weeks of treatment. This sustained suppression is the main therapeutic goal of androgen deprivation therapy (ADT), as low testosterone slows prostate cancer growth.

Although lowering prostate-specific antigen (PSA) was not a primary endpoint of the trials, patients treated with Orgovyx also experienced decreases in PSA levels, which is a biomarker used to monitor prostate cancer activity. Trial summaries report that average PSA levels dropped by about 65% by day 15 and by approximately 83% by day 29 after starting Orgovyx. Further monitoring indicated that PSA continued to stay low through the 48-week treatment period.

To add, a 54% lower incidence of major adverse cardiac events was reported in men treated with Orgovyx vs leuprolide. Among men taking losartan, sustained castration was 95.4% with relugolix compared with 80.6% with leuprolide. Similar patterns were seen with amlodipine, metoprolol, aspirin, clopidogrel, and simvastatin.

Companies often argue that this added value justifies a higher price.

5. US pricing policies

Unlike many countries, the United States does not negotiate drug prices at the federal level. Manufacturers set launch prices and often increase them yearly. As a result, US prices for brand-name drugs are two to three times higher than those in comparable countries like Canada.

State-level specialty drug caps can mitigate these costs, but only a handful of states have adopted them. Such caps are associated with a 32% reduction in patient spending.

How insurance and Medicare affect Orgovyx price

Insurance coverage can significantly change what you actually pay for Orgovyx.

Commercial insurance

Most private insurance plans require prior authorization for Orgovyx, meaning your doctor must justify its use before coverage begins. Once approved, patients usually pay a percentage of the cost (coinsurance) or a set co-pay.

The manufacturer of Orgovyx offers a Copay Assistance Program that can reduce co-pays to as little as $10 per month for eligible commercially insured patients, with an annual maximum savings of $10,000.

If your insurance plan initially denies coverage, the Bridge Program may provide a free four-month supply while an appeal is processed.

Medicare

People on Medicare cannot use the manufacturer copay card, but help is still available:

    • Medicare Part D Extra Help: This federal program assists low-income beneficiaries with premiums and drug costs. It may substantially reduce out-of-pocket expenses.
    • 2026 Part D cap: Beginning in 2026, Medicare Part D will limit annual out-of-pocket drug spending to $2,100. This cap will benefit patients requiring expensive medications like Orgovyx.
    • State assistance programs: Some states cap monthly or yearly spending on specialty drugs at amounts such as $150 per 30-day supply.

A 2021 cost analysis estimated that Medicare patients paid about $3,731 out of pocket per year for relugolix therapy.

Medicaid and other programs

Medicaid coverage varies by state. Eligibility and co-pays depend on income and local policies. For people who fall into the coverage gap, nonprofit organizations such as the Patient Access Network Foundation or NeedyMeds may offer grants or discount cards.

Ways to save on Orgovyx

Several savings options may help lower your out-of-pocket expenses:

Manufacturer assistance programs

Orgovyx is developed and commercialized by Myovant Sciences, Inc., in partnership with Pfizer, Inc., under a collaboration agreement for development and marketing, particularly in the US and Canada.

They offer several patient support and financial assistance options for Orgovyx. These include both copay savings and full assistance programs for those with financial need:

    1. Copay Assistance Program: Eligible commercially insured patients may pay as little as $10 per month, up to an annual savings limit of $10,000. You cannot combine this program with federal insurance like Medicare or Medicaid.
    2. Bridge Program: Provides a free supply for up to four months if there is an insurance delay or if you are waiting for prior authorization.

Third-party financial assistance

Organizations such as the Patient Access Network Foundation, Medicine Assistance Tool, and NeedyMeds offer grants and resources to reduce drug costs for people with limited incomes.

Practical cost-saving strategies

  • Ask for a 90-day supply. Filling a three-month prescription may reduce the per-tablet price and reduce your pharmacy visits.
  • Use mail-order or specialty pharmacies. Mail-order services often negotiate better prices and may offer home delivery.
  • Compare pharmacies. Prices can vary widely between pharmacies, so it may be worthwhile to call several or use a pharmacy comparison tool.
  • Check for rebates or coupons. Some pharmacies accept manufacturer coupons or discount cards, though these are generally not usable with Medicare or Medicaid.
  • Speak to your oncologist. Your doctor may be able to recommend alternative therapies or help with appeals if your insurer denies coverage.
Orgovyx coupons and discounts

Get a 90-day supply of 120 mg Orgovyx for $1,230!

A valid prescription is required.

SAVE 10% with coupon code:

Will Orgovyx become more affordable?

Drug prices often decline only when generics become available. Patents typically last 15-20 years from the date of filing, meaning a generic form of relugolix may not emerge for several years. However, upcoming policy changes may help:

    • Medicare Part D cap: The 2026 cap on out-of-pocket spending should protect seniors from the brunt of high drug costs.
    • State-level price caps: More states may adopt specialty drug caps similar to those already enacted.
    • International price referencing: There is growing political pressure to align US drug prices with those paid in other countries. Legislative changes in this direction could eventually lower prices.

Despite these potential changes, the price of Orgovyx is likely to remain high until generic competition enters the market.

Bottom line

Orgovyx offers men with advanced prostate cancer a convenient alternative to injections, but the convenience comes at a high cost. US monthly prices exceed $2,000, and the absence of a generic keeps costs high.

You can reduce your out-of-pocket expenses by using manufacturer copay programs, exploring charitable assistance, obtaining 90-day supplies, and staying informed about upcoming Medicare changes. Talking with your healthcare team about insurance coverage, financial assistance, and potential alternatives is essential to ensure you receive the care you need without undue financial strain.

Related Articles

Frequently Asked Questions

Orgovyx is costly because it is the only oral GnRH antagonist for prostate cancer and enjoys market exclusivity. The high price reflects decades of research, clinical trials, complex manufacturing, and patent protection. Cancer drug launch prices often exceed $100?000 per year, and companies set prices according to what the market can bear.

Retail prices vary, but a 30-day supply generally costs between $2,313 and $2,787 in the United States.

No. Orgovyx is only available as a brand-name drug, and no generic relugolix is currently approved.

Yes. Orgovyx is covered under most Medicare Part?D plans, but prior authorization is often required.

No. Manufacturer copay assistance programs are only for patients with commercial insurance. Medicare and Medicaid beneficiaries are not eligible.

This program reduces co-pays to as little as $10 per month for eligible commercially insured patients and provides savings up to $10,000 per year.

The Bridge Program offers a free four-month supply if your insurance approval is delayed, giving you time to appeal coverage decisions.

If you qualify for Medicare’s Extra Help program, your prescription costs, including Orgovyx, may be significantly reduced. Contact Social Security or your local State Health Insurance Assistance Program for eligibility details.

Coverage varies by state. Some state Medicaid programs cover Orgovyx with prior authorization, while others may require the use of lower-cost alternatives first. Check with your state Medicaid office.

Enroll in the Copay Assistance Program, request a 90-day prescription to lower per-tablet costs, and consider specialty pharmacies that may offer lower prices.

Yes. Organizations such as the Patient Access Network Foundation, Medicine Assistance Tool, and NeedyMeds offer grants and resources to help with high prescription costs.

Some patients consider buying Orgovyx from Canada to save money, but safety and legality matter. At Pharma Giant, a 30-day supply of 120 mg Orgovyx tablets costs $419.99, and a 10% discount lowers it to about $377.99. A valid prescription is required. Avoid websites that do not require one.

Ask your prescribing physician to write a 90-day prescription. Then check with your insurance plan and pharmacy to ensure they allow 90-day fills for specialty medications. Mail-order pharmacies often offer these supplies.

The timing depends on patent expiration and regulatory approval. Patents typically protect a drug for many years, so a generic relugolix is unlikely to arrive until the late 2020s or early 2030s.

Injectable therapies like leuprolide (Lupron) have generic versions priced around $2,729 per injection. However, injections are given every one to three months and may not be appropriate for everyone. Always consult your oncologist before switching therapies.

Common side effects of Orgovyx include symptoms typical of ADT, such as hot flashes, fatigue or tiredness, muscle and joint pain, constipation, and diarrhea. Many patients also experience changes in metabolism, like increased blood sugar and increased blood fats (triglycerides), as well as decreased hemoglobin (red blood cells), and elevated liver enzymes.

Sources

Jazowski, S. A., Nayak, R. K., & Dusetzina, S. B. (2024). The high costs of anticancer therapies in the USA: challenges, opportunities and progress. Nature Reviews Clinical Oncology, 21(12), 888–899. https://doi.org/10.1038/s41571-024-00948-1

Goodwin, K. (2022, June 30). FDA approves Myovant drug Orgovyx as First-Ever oral hormone therapy for prostate cancer. BioSpace. https://www.biospace.com/first-oral-drug-for-prostate-cancer-approved

Shore, N. D., Mehlhaff, B. A., Cookson, M. S., Saltzstein, D. R., Tutrone, R., Brown, B., Lu, S., Fallick, M., Hanson, S., & Saad, F. (2023). Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer. Advances in Therapy, 40(11), 4919–4927. https://doi.org/10.1007/s12325-023-02634-7

About Orgovyx. (n.d.). ORGOVYX. https://www.orgovyx.com/about-orgovyx/

Borrelli, E., & McGladrigan, C. (2021). PCN80 Estimating the Difference in Annual out-of-Pocket Costs for Relugolix and Leuprolide for Medicare Patients with Metastatic Prostate Cancer. Value in Health, 24, S34. https://doi.org/10.1016/j.jval.2021.04.172